Theyre often prescribed to help manage insulin resistance, prediabetes, blood sugar variability, and PCOSall of which can be affected by the hormonal changes of menopause
doi:10.1111/dom.14551
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well-established therapeutic agents that exert potent glucose-lowering effects by stimulating insulin secretion, suppressing glucagon secretion in a glucose-dependent manner, and delaying gastric emptying (1)
After statistics, we found that the expression of these proteins decreased after PA modeling, and increased after adding berberine, while after giving GLP-1R inhibitor, this trend of berberine was inhibited (Figures 5CG)
Overall, the effect of GLP-1RAs on muscle mass shows a high degree of heterogeneity in clinical trials: some studies report that lean body mass reduction accounts for 40% to 60% of total weight loss, while others indicate that the proportion of lean body mass reduction is approximately 15% or lower [50]
This ingredient is typically used at low levels (up to 2.5% in eyeshadow and 1% in lipstick)